Los Angeles, CA –September 3, 2025 – Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents.
News
News
Los Angeles, CA – August 14, 2025 – The Terasaki Institute for Biomedical Innovation is pleased to announce its 2025 Media Contest, inviting creative individuals worldwide to visually explore the fields of biomedical science and engineering. The contest accepts submissions in video, animation, and image formats—including AI-generated art—that capture the innovative spirit driving advances in healthcare.
Los Angeles, CA – August 14, 2025 - The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a life-threatening syndrome responsible for over one-third of cancer-related deaths. Published in Cell, the study led by Dr. Aliesha O’Raw, Principal Investigator at the Institute, demonstrates that modulating the vagus nerve can effectively halt the progression of cachexia, enhance chemotherapy outcomes, and improve survival in preclinical models.
Los Angeles, CA – July 22, 2025 - The Terasaki Institute for Biomedical Innovation is proud to spotlight its 2025 Summer Internship Program, celebrating the energy, curiosity, and creativity of this year’s dynamic intern cohort. Now in full swing, the program welcomes 27 interns across three focus areas: biomedical research, innovation, and marketing.
Los Angeles, CA – June 24, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) is proud to announce that Dr. Yangzhi Zhu, Assistant Professor at TIBI, has been honored with the 2024 Biosensors Young Investigator Award.
Los Angeles, CA – June 12, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) is proud to be featured in Cell Biomaterials by Cell Press, highlighting key moments and insights from our 2025 Terasaki Innovation Summit. The article captures powerful reflections from world-renowned leaders in bioengineering, regenerative medicine, AI-powered healthcare, and translational science, all united by a shared mission to advance human health through innovation.
Los Angeles, CA – May 29, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) and California State University, Northridge (CSUN) are proud to announce the launch of a new collaboration initiative that brings advanced hands-on laboratory experience to CSUN Biology graduate students as part of their curriculum.
Los Angeles, CA - May 22, 2025 – Scientists at the Terasaki Institute for Biomedical Innovation (TIBI), led by Dr. Vadim Jucaud (Assistant Professor), have engineered a novel multi-cellular 3D glioblastoma (GBM) in vitro model that mimics the biomechanical properties of brain tissue and the role of pericytes in glioblastoma (GBM) resistance to temozolomide (TMZ), the standard-of-care chemotherapy for this deadly brain cancer.